| Ragini Vykunta, MD | |
|
39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 | |
| (510) 795-3000 | |
| Not Available |
| Full Name | Ragini Vykunta |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 39400 Paseo Padre Pkwy, Fremont, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750466421 | NPI | - | NPPES |
| 00A769140 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A76914 (California) | Primary |
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Stem cell researchers exploring a new approach for the care of respiratory diseases report that an experimental treatment involving transplantable lung cells was associated with improved outcomes in tests on mice with acute lung injury. The lung cells were derived from human embryonic stem cells (hESCs). Findings by investigators at The University of Texas Health Science Center at Houston are scheduled to appear in the March issue of Molecular Therapy.
The drug, dutasteride, suppresses blood flow in benign tissue of the prostate, allowing radiologists to better target cancer tissue using Doppler ultrasound, said Elizabeth Ives, MD, a research fellow at Thomas Jefferson University Hospital in Philadelphia and lead author of the study.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
Fate Therapeutics, Inc. announced today a definitive agreement to acquire Verio Therapeutics Inc., a privately held biotechnology company based in Ottawa, Ontario, which is developing drug candidates targeting the activation of endogenous stem cells. Verio Therapeutics is advancing the work of several of Canada's leading stem cell scientists, including Michael Rudnicki, Ph.D., FRSC, and Lynn Arthur Megeney, Ph.D., who have made breakthrough discoveries relating to muscle and pancreatic regeneration.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ragini Vykunta, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Ragini Vykunta, MD 39400 Paseo Padre Pkwy, Fremont, CA 94538-2310 Ph: (510) 795-3000 |
News Archive
Stem cell researchers exploring a new approach for the care of respiratory diseases report that an experimental treatment involving transplantable lung cells was associated with improved outcomes in tests on mice with acute lung injury. The lung cells were derived from human embryonic stem cells (hESCs). Findings by investigators at The University of Texas Health Science Center at Houston are scheduled to appear in the March issue of Molecular Therapy.
The drug, dutasteride, suppresses blood flow in benign tissue of the prostate, allowing radiologists to better target cancer tissue using Doppler ultrasound, said Elizabeth Ives, MD, a research fellow at Thomas Jefferson University Hospital in Philadelphia and lead author of the study.
Roche, makers of ACCU-CHEK® blood glucose meters, infusion pumps, lancing devices and data management systems for people with diabetes, received the Juvenile Diabetes Research Foundation International's "Chancellor's Award" during the JDRF Annual Conference in Washington, D.C. The "Chancellor's Award" recognizes and honors longstanding JDRF corporate partners.
Fate Therapeutics, Inc. announced today a definitive agreement to acquire Verio Therapeutics Inc., a privately held biotechnology company based in Ottawa, Ontario, which is developing drug candidates targeting the activation of endogenous stem cells. Verio Therapeutics is advancing the work of several of Canada's leading stem cell scientists, including Michael Rudnicki, Ph.D., FRSC, and Lynn Arthur Megeney, Ph.D., who have made breakthrough discoveries relating to muscle and pancreatic regeneration.
› Verified 2 days ago
Shambhavi Iyer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Karuna Gudur, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Niti K. Mann, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Tabassum Alam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
David T. Chiu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Savitha Sundararaj, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 | |
Mayura Suryanarayan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-795-3000 |